Abstract
Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be observed even with hemoglobin S.
Author supplied keywords
Cite
CITATION STYLE
APA
Moiz, B., & Majeed, A. (2018, June 1). No risk reduction for Plasmodium vivax malaria in sickle cell disease. Clinical Case Reports. Wiley-Blackwell Publishing Ltd. https://doi.org/10.1002/ccr3.1507
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free